$CPIX
CUMBERLAND PHARMACEUTICALS INC Stock $cpix

$cpix Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000162828023007727 Filed on March 13, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$9.225M	$9.124M	$42.01M
YoY Change	-17.45%	9.66%	16.75%
Cost Of Revenue	$1.250M	$4.450M	$9.119M
YoY Change	-43.48%	99.99%	3.49%
Gross Profit	$7.974M	$4.673M	$32.89M
YoY Change	-11.03%	-23.32%	21.04%
Gross Profit Margin	86.45%	51.22%	78.29%
Selling, General & Admin	$6.776M	$6.887M	$26.84M
YoY Change	-2.03%	2.51%	8.25%
% of Gross Profit	84.98%	147.37%	81.6%
Research & Development	$1.500M	$1.406M	$6.689M
YoY Change	-14.07%	-12.83%	17.67%
% of Gross Profit	18.81%	30.08%	20.34%
Depreciation & Amortization	$1.256M	$511.5K	$5.328M
YoY Change	-24.07%	-52.51%	15.67%
% of Gross Profit	15.75%	10.94%	16.2%
Operating Expenses	$8.276M	$8.751M	$33.53M
YoY Change	-4.46%	-6.39%	10.01%
Operating Profit	-$1.532M	-$2.278M	-$5.705M
YoY Change	18.55%	-47.68%	-25.69%
Interest Expense	$186.4K	-$133.8K	$586.0K
YoY Change	55.85%	535.14%	497.76%
% of Operating Profit
Other Income/Expense, Net	$1.847M	$0.00	$611.3K
YoY Change			-72.05%
Pretax Income	$179.2K	-$2.412M	-$5.581M
YoY Change	-112.84%	-44.88%	0.34%
Income Tax	$6.938K	$48.15K	$68.85K
% Of Pretax Income	3.87%
Net Earnings	$192.2K	-$2.441M	-$5.570M
YoY Change	-113.87%	-36.57%	58.81%
Net Earnings / Revenue	2.08%	-26.75%	-13.26%
Basic Earnings Per Share	$0.01	-$0.17	-$0.38
Diluted Earnings Per Share	$0.01	-$0.17	-$0.38
COMMON SHARES
Basic Shares Outstanding	14.40M shares	14.46M shares	14.56M shares
Diluted Shares Outstanding	14.59M shares		14.56M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$16.39M	$19.76M	$19.76M
YoY Change	-5.1%	-26.93%	-26.93%
Cash & Equivalents	$16.39M	$19.76M	$19.76M
Short-Term Investments
Other Short-Term Assets	$2.715M	$3.085M	$3.085M
YoY Change	-23.74%	-7.63%	-7.63%
Inventory	$10.18M	$9.864M	$9.864M
Prepaid Expenses
Receivables	$14.53M	$13.16M	$13.16M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$43.81M	$45.87M	$45.87M
YoY Change	-3.38%	0.4%	0.4%
LONG-TERM ASSETS
Property, Plant & Equipment	$354.9K	$284.0K	$5.502M
YoY Change	-13.26%	-35.83%	275.12%
Goodwill	$914.0K	$914.0K
YoY Change	-52.71%	3.63%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.545M	$2.521M	$10.05M
YoY Change	-19.93%	-26.29%	-19.41%
Total Long-Term Assets	$45.66M	$47.05M	$47.05M
YoY Change	-11.09%	21.36%	21.36%
TOTAL ASSETS
Total Short-Term Assets	$43.81M	$45.87M	$45.87M
Total Long-Term Assets	$45.66M	$47.05M	$47.05M
Total Assets	$89.47M	$92.93M	$92.93M
YoY Change	-7.48%	10.02%	10.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$11.22M	$10.82M	$10.82M
YoY Change	-1.97%	12.22%	12.22%
Accrued Expenses	$158.4K	$17.59M	$2.223M
YoY Change	-79.34%	102.9%	-4.52%
Deferred Revenue		$614.6K
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$25.71M	$28.58M	$28.58M
YoY Change	4.68%	48.24%	48.24%
LONG-TERM LIABILITIES
Long-Term Debt	$16.07M	$16.20M	$16.20M
YoY Change	-19.64%	8.0%	8.0%
Other Long-Term Liabilities	$7.091M	$7.585M	$12.17M
YoY Change	-37.5%	1.28%	60.6%
Total Long-Term Liabilities	$7.091M	$7.585M	$28.37M
YoY Change	-77.38%	1.28%	25.65%
TOTAL LIABILITIES
Total Short-Term Liabilities	$25.71M	$28.58M	$28.58M
Total Long-Term Liabilities	$7.091M	$7.585M	$28.37M
Total Liabilities	$53.42M	$56.95M	$56.66M
YoY Change	-4.44%	36.06%	36.05%
SHAREHOLDERS EQUITY
Retained Earnings	-$11.02M	-$11.21M
YoY Change	56.85%	98.79%
Common Stock	$47.38M	$47.47M
YoY Change	-1.39%	-2.02%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$36.36M	$36.27M	$36.27M
YoY Change
Total Liabilities & Shareholders Equity	$89.47M	$92.93M	$92.93M
YoY Change	-7.48%	10.02%	10.02%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	$192.2K	-$2.441M	-$5.570M
YoY Change	-113.87%	-36.57%	58.81%
Depreciation, Depletion And Amortization	$1.256M	$511.5K	$5.328M
YoY Change	-24.07%	-52.51%	15.67%
Cash From Operating Activities	-$1.418M	$3.638M	$8.453M
YoY Change	842.34%	85.64%	33.28%
INVESTING ACTIVITIES
Capital Expenditures	$107.3K	$1.641M	$102.1K
YoY Change	297.47%	-2167.5%	-1.34%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$1.000M	-$11.60M
YoY Change	-100.0%	1802.23%	7768.58%
Cash From Investing Activities	-$174.5K	-$640.8K	-$13.67M
YoY Change	-98.71%	2291.86%	2624.58%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$1.053M
YoY Change			-24.07%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$1.779M	-2.781M	-$2.062M
YoY Change	-145.41%	278.19%	-41.98%
NET CHANGE
Cash From Operating Activities	-$1.418M	3.638M	$8.453M
Cash From Investing Activities	-$174.5K	-640.8K	-$13.67M
Cash From Financing Activities	-$1.779M	-2.781M	-$2.062M
Net Change In Cash	-$3.372M	216.4K	-$7.283M
YoY Change	-65.5%	-81.93%	-418.44%
FREE CASH FLOW
Cash From Operating Activities	-$1.418M	$3.638M	$8.453M
Capital Expenditures	$107.3K	$1.641M	$102.1K
Free Cash Flow	-$1.525M	$1.997M	$8.351M
YoY Change	759.5%	-2.05%	33.86%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001087294
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Entity Registrant Name EntityRegistrantName	CUMBERLAND PHARMACEUTICALS INC
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	TN
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	62-1765329
CY2022	dei	Entity File Number EntityFileNumber	001-33637
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	1600 West End Avenue
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1300
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Nashville
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	TN
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	37203
CY2022	dei	City Area Code CityAreaCode	615
CY2022	dei	Local Phone Number LocalPhoneNumber	255-0068
CY2022	dei	Security12b Title Security12bTitle	Common Stock, $0.00 par value per share
CY2022	dei	Trading Symbol TradingSymbol	CPIX
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022Q2	dei	Entity Public Float EntityPublicFloat	17300356	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	14395401	shares
CY2022	dei	Auditor Firm AuditorFirmId	686
CY2022	dei	Auditor Name AuditorName	FORVIS, LLP(Formerly, BKD, LLP)
CY2022	dei	Auditor Location AuditorLocation	Nashville, Tennessee
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19757970	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	27040816	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	13163681	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6877346	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	9863581	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	8429882	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3084978	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3339969	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	45870210	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	45688013	usd
CY2022Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	7527167	usd
CY2021Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	9048567	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	284039	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	442635	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	30590678	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	23954475	usd
CY2022Q4	us-gaap	Goodwill Goodwill	914000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	882000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5218403	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1024200	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2520661	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3419908	usd
CY2022Q4	us-gaap	Assets Assets	92925158	usd
CY2021Q4	us-gaap	Assets Assets	84459798	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	10819011	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	9640980	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	172910	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	969677	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	17587911	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8668303	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	28579832	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	19278960	usd
CY2022Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	16200000	usd
CY2021Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	15000000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4586301	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	90016	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	7585019	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	7488844	usd
CY2022Q4	us-gaap	Liabilities Liabilities	56951152	usd
CY2021Q4	us-gaap	Liabilities Liabilities	41857820	usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2021Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14366316	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14366316	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14742754	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14742754	shares
CY2022Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	47474973	usd
CY2021Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	48452906	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-11208841	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-5638600	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	36266132	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	42814306	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	-292126	usd
CY2021Q4	us-gaap	Minority Interest MinorityInterest	-212328	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	35974006	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	42601978	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	92925158	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	84459798	usd
CY2022	us-gaap	Revenues Revenues	42010949	usd
CY2021	us-gaap	Revenues Revenues	35985043	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	9118521	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	8811248	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	16660945	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	15015424	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6688924	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5684465	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5581189	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10180120	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9780026	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5067368	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4371300	usd
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	47715878	usd
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	43662463	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-5704929	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-7677420	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	98405	usd
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	26081	usd
CY2022	us-gaap	Other Income OtherIncome	0	usd
CY2021	us-gaap	Other Income OtherIncome	2187140	usd
CY2022	us-gaap	Insured Event Gain Loss InsuredEventGainLoss	611330	usd
CY2021	us-gaap	Insured Event Gain Loss InsuredEventGainLoss	0	usd
CY2022	us-gaap	Interest Expense InterestExpense	585995	usd
CY2021	us-gaap	Interest Expense InterestExpense	98031	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5562230	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	68850	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	34891	usd
CY2022	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-5650039	usd
CY2021	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-5597121	usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	0	usd
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	1994322	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-5650039	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-3602799	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-79798	usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-95212	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5570241	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-3507587	usd
CY2022	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.38
CY2021	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.37
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.13
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.38
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.24
CY2022	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.38
CY2021	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.37
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.13
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.38
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.24
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14563592	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14904834	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14563592	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14904834	shares
CY2022	us-gaap	Profit Loss ProfitLoss	-5650039	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-3602799	usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	0	usd
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	1994322	usd
CY2022	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-5650039	usd
CY2021	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-5597121	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5328113	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4606366	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	447503	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	741867	usd
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	2088296	usd
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	1147750	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	11237	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	34053	usd
CY2022	cpix	Noncash Or Part Noncash Gain On Transaction NoncashOrPartNoncashGainOnTransaction	37882	usd
CY2021	cpix	Noncash Or Part Noncash Gain On Transaction NoncashOrPartNoncashGainOnTransaction	0	usd
CY2022	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	611330	usd
CY2021	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	0	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	0	usd
CY2021	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	2187140	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6115640	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-5500367	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-911078	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-4816450	usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-689260	usd
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	35568	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	14536076	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-757591	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	419659	usd
CY2021	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-1343605	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	8453396	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	4348121	usd
CY2022	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	0	usd
CY2021	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	1994322	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	8453396	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	6342443	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	102148	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	103532	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1971662	usd
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	250930	usd
CY2022	cpix	Proceeds From Collaboration Arrangement ProceedsFromCollaborationArrangement	1000000	usd
CY2021	cpix	Proceeds From Collaboration Arrangement ProceedsFromCollaborationArrangement	0	usd
CY2022	us-gaap	Proceeds From Life Insurance Policies ProceedsFromLifeInsurancePolicies	877597	usd
CY2022	cpix	Financial Consideration Number Of Installments FinancialConsiderationNumberOfInstallments	4	installment
CY2021	us-gaap	Proceeds From Life Insurance Policies ProceedsFromLifeInsurancePolicies	0	usd
CY2022	cpix	Proceeds From Settlement Of Patent Litigation ProceedsFromSettlementOfPatentLitigation	21757	usd
CY2021	cpix	Proceeds From Settlement Of Patent Litigation ProceedsFromSettlementOfPatentLitigation	0	usd
CY2022	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	13500000	usd
CY2021	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	0	usd
CY2022	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	0	usd
CY2021	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	200000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-13674456	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-501893	usd
CY2022	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	52900000	usd
CY2021	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	59000000	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	51700000	usd
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	59000000	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1053042	usd
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1386849	usd
CY2022	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	2208744	usd
CY2021	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	2166681	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2061786	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3553530	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-7282846	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2287020	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	27040816	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24753796	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19757970	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	27040816	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	523161	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	63978	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	3300	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-327	usd
CY2022	cpix	Purchases Of Intangible Assets Incurred But Not Yet Paid PurchasesOfIntangibleAssetsIncurredButNotYetPaid	-1803403	usd
CY2021	cpix	Purchases Of Intangible Assets Incurred But Not Yet Paid PurchasesOfIntangibleAssetsIncurredButNotYetPaid	-43471	usd
CY2022	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	94689	usd
CY2021	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	90512	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	4590978	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2022	cpix	Credit Issued For Milestone Payable CreditIssuedForMilestonePayable	-1000000	usd
CY2021	cpix	Credit Issued For Milestone Payable CreditIssuedForMilestonePayable	0	usd
CY2022	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	399600	usd
CY2021	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	0	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	46873394	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-3602799	usd
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	741867	usd
CY2021	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1410484	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	42601978	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-5650039	usd
CY2022	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	399600	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	447503	usd
CY2022	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1025836	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	35974006	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-79798	usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-95212	usd
CY2018	cpix	Sharebased Compensation Charitable Contributionof Shares Shares SharebasedCompensationCharitableContributionofSharesShares	50000	shares
CY2019	cpix	Share Based Compensation Charitable Contribution Of Shares Committed Cash Contributions ShareBasedCompensationCharitableContributionOfSharesCommittedCashContributions	50000	usd
CY2020	cpix	Share Based Compensation Charitable Contribution Of Shares Committed Cash Contributions ShareBasedCompensationCharitableContributionOfSharesCommittedCashContributions	25000	usd
CY2022	cpix	Share Based Compensation Charitable Contribution Of Shares Cash Contributions ShareBasedCompensationCharitableContributionOfSharesCashContributions	25000	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	Use of EstimatesThe preparation of the consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management of the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates under different assumptions and conditions.
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2022	us-gaap	Consideration Received For Beneficial Interest Obtained For Transferring Financial Asset ConsiderationReceivedForBeneficialInterestObtainedForTransferringFinancialAsset	2000000	usd
CY2018Q1	cpix	Stock Issued During Period Shelf Registration Proceeds From Saleof Corporate Securities StockIssuedDuringPeriodShelfRegistrationProceedsFromSaleofCorporateSecurities	100000000	usd
CY2021Q4	cpix	Stock Issued During Period Shelf Registration Proceeds From Saleof Corporate Securities StockIssuedDuringPeriodShelfRegistrationProceedsFromSaleofCorporateSecurities	19000000	usd
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2021	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-5447420	usd
CY2022	us-gaap	Production And Distribution Costs ProductionAndDistributionCosts	857842	usd
CY2021	us-gaap	Production And Distribution Costs ProductionAndDistributionCosts	806311	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	2927041	usd
CY2021	us-gaap	Advertising Expense AdvertisingExpense	1927864	usd
CY2022Q4	us-gaap	Other Inventory Materials Supplies And Merchandise Under Consignment OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment	168923	usd
CY2022Q4	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	3800000	usd
CY2022	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	40000.00	usd
CY2021Q4	us-gaap	Other Inventory Materials Supplies And Merchandise Under Consignment OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment	164378	usd
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	1000000	usd
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	1000000	usd
CY2022	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	42010949	usd
CY2021	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	50085043	usd
CY2022	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-5704929	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	40681182	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	35045259	usd
CY2022	cpix	Revenue Recognition Upfront Payment RevenueRecognitionUpfrontPayment	1500000	usd
CY2022	cpix	Revenue Recognition Potential Upfront Payments Relatedto Regulatory Approval RevenueRecognitionPotentialUpfrontPaymentsRelatedtoRegulatoryApproval	2400000	usd
CY2022	cpix	Revenue Recognition Potential Upfront Payment Relatedto Product Sales RevenueRecognitionPotentialUpfrontPaymentRelatedtoProductSales	5600000	usd
CY2022	cpix	Revenue Recognition Cumulative Upfront Payment RevenueRecognitionCumulativeUpfrontPayment	1900000	usd
CY2022	cpix	Revenue Recognition Milestone Payments RevenueRecognitionMilestonePayments	500000	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	12899659	usd
CY2021Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	12374983	usd
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	4322167	usd
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	4939088	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	17390748	usd
CY2021Q4	us-gaap	Inventory Gross InventoryGross	17478449	usd
CY2022Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	7527167	usd
CY2021Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	9048567	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	9863581	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	8429882	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	500000	usd
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1400000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2369224	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4234788	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2085185	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3792153	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	284039	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	442635	usd
CY2022	cpix	Depreciation Including Amortization Related To Leasehold Improvements DepreciationIncludingAmortizationRelatedToLeaseholdImprovements	260745	usd
CY2021	cpix	Depreciation Including Amortization Related To Leasehold Improvements DepreciationIncludingAmortizationRelatedToLeaseholdImprovements	235066	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	30590678	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	23954475	usd
CY2022Q4	us-gaap	Goodwill Goodwill	914000	usd
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Goodwill Goodwill	882000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5067368	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4371300	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	4736657	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	4687365	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	4652156	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	4092961	usd
CY2022Q4	cpix	Finite Lived Intangible Assets Amortization Expense Year Fiveand After FiniteLivedIntangibleAssetsAmortizationExpenseYearFiveandAfter	12421539	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	30590678	usd
CY2022Q4	cpix	Product Sales Related Liabilities Current ProductSalesRelatedLiabilitiesCurrent	8347214	usd
CY2021Q4	cpix	Product Sales Related Liabilities Current ProductSalesRelatedLiabilitiesCurrent	3680677	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1440859	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1340846	usd
CY2022Q4	cpix	Accrued Liabilities Stock Payable AccruedLiabilitiesStockPayable	2226725	usd
CY2021Q4	cpix	Accrued Liabilities Stock Payable AccruedLiabilitiesStockPayable	0	usd
CY2022Q4	cpix	Business Combination Contingent Consideration Liability Accrued Current BusinessCombinationContingentConsiderationLiabilityAccruedCurrent	3006310	usd
CY2021Q4	cpix	Business Combination Contingent Consideration Liability Accrued Current BusinessCombinationContingentConsiderationLiabilityAccruedCurrent	2685531	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	614551	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	0	usd
CY2022Q4	cpix	Accrued Liabilities Inventory Purchases AccruedLiabilitiesInventoryPurchases	609621	usd
CY2021Q4	cpix	Accrued Liabilities Inventory Purchases AccruedLiabilitiesInventoryPurchases	18211	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1342631	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	943038	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	17587911	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8668303	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	4931513	usd
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	3830096	usd
CY2022Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	2522506	usd
CY2021Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	3433962	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Noncurrent AccountsPayableAndAccruedLiabilitiesNoncurrent	131000	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Noncurrent AccountsPayableAndAccruedLiabilitiesNoncurrent	224786	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	7585019	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	7488844	usd
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2022	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-5650039	usd
CY2021	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-5597121	usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	0	usd
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	1994322	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-5650039	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-3602799	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-79798	usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-95212	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5570241	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-3507587	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14563592	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14904834	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14563592	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14904834	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	227050	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	183300	shares
CY2022Q4	cpix	Deferred Tax Assets Operating Loss Carryforwards And Tax Credit Carryforwards DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards	16164754	usd
CY2021Q4	cpix	Deferred Tax Assets Operating Loss Carryforwards And Tax Credit Carryforwards DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards	16817070	usd
CY2022Q4	cpix	Deferred Tax Assets Property And Equipment And Intangibles DeferredTaxAssetsPropertyAndEquipmentAndIntangibles	264653	usd
CY2021Q4	cpix	Deferred Tax Assets Property And Equipment And Intangibles DeferredTaxAssetsPropertyAndEquipmentAndIntangibles	222893	usd
CY2022Q4	cpix	Deferred Tax Asset Operating Lease Liabilities DeferredTaxAssetOperatingLeaseLiabilities	1121800	usd
CY2021Q4	cpix	Deferred Tax Asset Operating Lease Liabilities DeferredTaxAssetOperatingLeaseLiabilities	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	866942	usd
CY2021Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	1481455	usd
CY2021Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	145803	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	83931	usd
CY2022Q4	cpix	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves For Expired Product DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReservesForExpiredProduct	654148	usd
CY2021Q4	cpix	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves For Expired Product DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReservesForExpiredProduct	457723	usd
CY2022Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	217025	usd
CY2021Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	104824	usd
CY2022Q4	cpix	Deferred Tax Assets Deferred Charges DeferredTaxAssetsDeferredCharges	1156150	usd
CY2021Q4	cpix	Deferred Tax Assets Deferred Charges DeferredTaxAssetsDeferredCharges	1303664	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	635989	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	834070	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	22708719	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	19824175	usd
CY2022Q4	cpix	Deferred Tax Liability Operating Lease Right Of Use Assets DeferredTaxLiabilityOperatingLeaseRightOfUseAssets	1150935	usd
CY2021Q4	cpix	Deferred Tax Liability Operating Lease Right Of Use Assets DeferredTaxLiabilityOperatingLeaseRightOfUseAssets	0	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	0	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	62253	usd
CY2022Q4	cpix	Net Deferred Tax Assets Gross NetDeferredTaxAssetsGross	21557784	usd
CY2021Q4	cpix	Net Deferred Tax Assets Gross NetDeferredTaxAssetsGross	19761922	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	21557784	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	19761922	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-68850	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-34891	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-68850	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-34891	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-61678	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	61678	usd
CY2022	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	68850	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	34891	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.02
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.01
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.22
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.19
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.02
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.04
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.01
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.01
CY2022	cpix	Share Based Compensation Arrangement By Share Based Payment Award Number Of Plans Available For Future Grants ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlansAvailableForFutureGrants	2	plan
CY2022	cpix	Share Based Compensation Arrangement By Share Based Payment Award Shareholder Percent ShareBasedCompensationArrangementByShareBasedPaymentAwardShareholderPercent	0.10
CY2018Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	800000	usd
CY2018	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y9M21D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	178950	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	186900	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.29
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.10
CY2022	cpix	Defined Contribution Plan Eligibility Minimum Employee Age DefinedContributionPlanEligibilityMinimumEmployeeAge	P21Y
CY2022	cpix	Defined Contribution Plan Eligibility Minimum Employee Service Time For Participation Eligibility DefinedContributionPlanEligibilityMinimumEmployeeServiceTimeForParticipationEligibility	P6M
CY2022	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	60000	usd
CY2021	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	50000	usd
CY2022Q4	us-gaap	Deferred Compensation Liability Current And Noncurrent DeferredCompensationLiabilityCurrentAndNoncurrent	2500000	usd
CY2021Q4	us-gaap	Deferred Compensation Liability Current And Noncurrent DeferredCompensationLiabilityCurrentAndNoncurrent	3400000	usd
CY2022Q4	us-gaap	Deferred Compensation Plan Assets DeferredCompensationPlanAssets	2300000	usd
CY2021Q4	us-gaap	Deferred Compensation Plan Assets DeferredCompensationPlanAssets	3200000	usd
CY2021Q4	cpix	Lessee Operating Lease Rent Increase LesseeOperatingLeaseRentIncrease	0.025
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	1159695	usd
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	1209102	usd
CY2022	us-gaap	Sublease Income SubleaseIncome	529411	usd
CY2021	us-gaap	Sublease Income SubleaseIncome	699889	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5218403	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1024200	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	172910	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	969677	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4586301	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	90016	usd
CY2022Q4	cpix	Lease Liability LeaseLiability	4759211	usd
CY2021Q4	cpix	Lease Liability LeaseLiability	1059693	usd
CY2022Q4	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	100000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	607061	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	575209	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	539347	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	604254	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	619354	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	5482220	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	8427445	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	3668234	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	4759211	usd
CY2020	us-gaap	Consideration Received For Beneficial Interest Obtained For Transferring Financial Asset ConsiderationReceivedForBeneficialInterestObtainedForTransferringFinancialAsset	5000000	usd
CY2022	cpix	Financial Consideration Payment Period FinancialConsiderationPaymentPeriod	P2Y
CY2022Q1	us-gaap	Revenues Revenues	11175045	usd
CY2022Q2	us-gaap	Revenues Revenues	10299152	usd
CY2022Q3	us-gaap	Revenues Revenues	11413072	usd
CY2022Q4	us-gaap	Revenues Revenues	9123680	usd
CY2022	us-gaap	Revenues Revenues	42010949	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1291999	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1846538	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-288588	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-2277804	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-5704929	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-1402433	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-1364666	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-423226	usd
CY2022Q4	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-2459714	usd
CY2022	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-5650039	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1385253	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-1335620	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-408639	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-2440729	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5570241	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.09
CY2022Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.09
CY2022Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.03
CY2022Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.17
CY2022	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.38
CY2022Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0
CY2022Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0
CY2022Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0
CY2022Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.38
CY2022Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.09
CY2022Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.09
CY2022Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.03
CY2022Q4	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.17
CY2022	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.38
CY2022Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0
CY2022Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0
CY2022Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0
CY2022Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.38
CY2021Q1	us-gaap	Revenues Revenues	10537159	usd
CY2021Q2	us-gaap	Revenues Revenues	9055483	usd
CY2021Q3	us-gaap	Revenues Revenues	8072540	usd
CY2021Q4	us-gaap	Revenues Revenues	8319861	usd
CY2021	us-gaap	Revenues Revenues	35985043	usd
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-324300	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1435729	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1563395	usd
CY2021Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-4353996	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-7677420	usd
CY2021Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-350749	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	724684	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-1583480	usd
CY2021Q4	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-4387576	usd
CY2021	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-5597121	usd
CY2021Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	495410	usd
CY2021Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	498807	usd
CY2021Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	496787	usd
CY2021Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	503318	usd
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	1994322	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	166828	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	1228560	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-1055278	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-3847697	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-3507587	usd
CY2021Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.02
CY2021Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.05
CY2021Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.10
CY2021Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.29
CY2021	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.37
CY2021Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.03
CY2021Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.03
CY2021Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.03
CY2021Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.03
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.13
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.08
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2021Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.26
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.24
CY2021Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.02
CY2021Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.05
CY2021Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.10
CY2021Q4	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.29
CY2021	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.37
CY2021Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.03
CY2021Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.03
CY2021Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.03
CY2021Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.03
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.13
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2021Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.26
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.24

Files In Submission

Name	View Source	Status
0001628280-23-007727-index-headers.html	Edgar Link	pending
0001628280-23-007727-index.html	Edgar Link	pending
0001628280-23-007727.txt	Edgar Link	pending
0001628280-23-007727-xbrl.zip	Edgar Link	pending
a2022-10kxex1011ajkazimi.htm	Edgar Link	pending
a2022-10kxex1014johnhamm.htm	Edgar Link	pending
a2022-10kxex1015jimherman.htm	Edgar Link	pending
a2022-10kxexhibit311.htm	Edgar Link	pending
a2022-10kxexhibit312.htm	Edgar Link	pending
a2022-10kxexhibit321.htm	Edgar Link	pending
a2022-xex232consentofforvi.htm	Edgar Link	pending
a2022q4exhibit411.htm	Edgar Link	pending
cpix-20221231.htm	Edgar Link	pending
cpix-20221231.xsd	Edgar Link	pending
cpix-20221231_g1.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
cpix-20221231_cal.xml	Edgar Link	unprocessable
cpix-20221231_def.xml	Edgar Link	unprocessable
cpix-20221231_lab.xml	Edgar Link	unprocessable
cpix-20221231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
cpix-20221231_htm.xml	Edgar Link	completed
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ssmithsign.jpg	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CPIX
CUMBERLAND PHARMACEUTICALS INC Stock $cpix

2023 Q1 Form 10-K Financial Statement

#000162828023007727 Filed on March 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CPIX CUMBERLAND PHARMACEUTICALS INC Stock $cpix

2023 Q1 Form 10-K Financial Statement

#000162828023007727 Filed on March 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CPIX
CUMBERLAND PHARMACEUTICALS INC Stock $cpix